Status:
UNKNOWN
Quality of Life in Head and Neck Patients
Lead Sponsor:
University of Brasilia
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Evaluation of health-related quality of life of head and neck cancer patients undergoing immunotherapy
Detailed Description
Introduction: The treatment of head and neck neoplasms, as well as the evolution of the disease, can affect a variety of body functions, including breathing, swallowing and speech, with great potentia...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of recurrent or metastatic squamous cell carcinoma of the head and neck region, whose planned treatment is immunotherapy, will be included. We will consider, separately, patients that had been treated with platinum before (platinum-refractory) and patients that were not submitted to this treatment (platinum naïve).
- Primary site: patients with primary pharyngeal tumors (oro or hypopharynx), oral cavity and larynx will be included.
Exclusion
- Patients with cognitive impairment that prevents the proper application of questionnaires
- Brain metastasis
- Autoimmune disease
- Systemic immunosuppressive treatment
- Hepatitis B, C or HIV infection
- Prior immunotherapy
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04853862
Start Date
May 1 2021
End Date
June 30 2023
Last Update
April 21 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.